AIM ImmunoTech Inc. (AMEX: AIM) last traded at $0.180, up 0.22% on the session. The quote above updates while this page is open; the figures below are drawn from AIM ImmunoTech Inc.’s own filings and are restated only when a new one is published.
AIM ImmunoTech Inc. trades on AMEX under the ticker AIM. Its market capitalisation is $5.48 million.
Valuation measures for AIM ImmunoTech Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $5.48M |
|---|---|
| Enterprise value | $566.6K |
| Price / sales | 57.68 |
| Price / book | 0.71 |
| Beta | 0.44 |
Trailing-twelve-month figures tagged in AIM ImmunoTech Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $95.0K |
|---|
| Net income (TTM) | -$14.27M |
|---|
| Operating margin | -11724.21% |
|---|
| Return on equity | -184.27% |
|---|
| Cash | $9.90M |
|---|
Range and volume for AIM over the past 52 weeks.
| 52-week high | $2.79 |
|---|---|
| 52-week low | $0.170 |
| Volume | 409.9K |
| Average volume | 4.64M |
| Previous close | $0.180 |
Invest a chosen dollar amount in AIM ImmunoTech Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell AIM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.